Quantitative evaluation of the FTA-ABS-IgM and VDRL test in treated and untreated syphilis.
AUTOR(ES)
Luger, A
RESUMO
Observations made on fluorescent treponemal antibody absorption (FTA-ABS) immunoglobulin M (IgM) titres in patients with untreated early syphilis showed non-reactive or weakly reactive results in patients with primary (one of five cases) and secondary (two of 16 cases) lesions. In patients with primary (19.5%) and secondary (15%) syphilis sera remained reactive with increased titres for more than one year after treatment. The respective figures in the results of the Venereal Disease Research Laboratory (VDRL) test were zero in primary and 20% in secondary syphilis. The non-reactive FTA-ABS IgM results may possibly be explained by competitive inhibition of IgM by immunoglobulin G (IgG). The persistence of reactivity in a comparable percentage has been observed by other investigators (Grin et al., 1974; Wilkinson and Rodin, 1976). The current results therefore suggest that FTA-ABS IgM titres are less reliable for assessing the effect of treatment than the course of the VDRL titres. The phenomenon of a decrease in FTA-ABS IgM titres soon after treatment with a later rise before final non-reactivity is a matter for further investigation.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1045423Documentos Relacionados
- IgM rheumatoid factor removal and performance of the FTA-ABS (IgM) test in congenital syphilis.
- IgM class antitreponemal antibody in treated and untreated syphilis.
- Demonstration of specific 19S(IgM) antibodies in untreated and treated syphilis. Comparative studies of the 19S(IgM)-FTA test, the 19S(IgM)-TPHA test, and the solid phase haemadsorption assay.
- The FTA-ABS test for syphilis. Performance in 1,033 patients.
- Treponema pallidum haemagglutination test for syphilis. Comparison with TPI and FTA-ABS tests.